Not the person you asked but this comes from the capital raising presentation last year:
Looks to be anticipated around late 2025. The reason they are already allowed to sell, is that the US FDA granted BUB a temporary exemption from the regulatory enforcement so that it could import its products. There are a lot of companies that have been granted the same exemption, the reason being to address formula shortages created by a contamination scandal awhile back.
Ann: Bubs Q2 FY24 Quarterly Activity and Cashflow Statement, page-19
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $120.4M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 14.5¢ | 13.0¢ | $435.1K | 3.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1920461 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 94096 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
-0.005 ( 6.05 %) |
||||
| Open | High | Low | Volume | ||
| 14.0¢ | 14.5¢ | 13.0¢ | 1825665 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| BUB (ASX) Chart |
